AnorMED gets OK to list shares on American Stock Exchange

By E. Janene Geiss

Philadelphia, Nov. 1 - AnorMED Inc. announced Tuesday that it was received approval to list its common shares on the American Stock Exchange under the symbol "AOM."

Along with its Amex application, the company filed a Form 40-F with the U.S. Securities and Exchange Commission to register its common shares, according to a company news release.

The company's registration has not yet become effective and the Amex approval is conditional on the SEC registration statement being declared effective, officials said.

AnorMED's common shares trade on the Toronto Stock Exchange under the symbol "AOM." Currently, there are about 31.8 million shares outstanding with 35.3 million shares fully diluted.

AnorMED is a Langley, B.C.-based chemistry-based pharmaceutical company focused on developing and commercializing therapeutic products for hematology, HIV and oncology.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.